{
 "PrintNo":"S6462","Session":2021,"Chamber":"SENATE","BillType":"Senate","Published":"2021-04-29T16:13:26.692082Z",
 "Status":"IN_SENATE_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2022-01-05","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2021-04-29","Chamber":"SENATE"},
  {"Text":"REFERRED TO HEALTH","Date":"2022-01-05","Chamber":"SENATE"}
 ],
 "Sponsors":[{"ID":888,"Name":"Leroy Comrie","Short":"COMRIE"}],
 "Title":"Limits the off label use of antipsychotic drugs on elderly patients with dementia",
 "Summary":"Limits the off label use of antipsychotic drugs with black box warnings on elderly patients with dementia; provides for professional misconduct for any health care professional who uses such drug on such patient.",
 "LawSection":"Public Health Law","LawCode":"Add ยง280-d, Pub Health L; amd ยง6530, Ed L",
 "ActClause":"AN ACT to amend the public health law, in relation to limiting the off label use of antipsychotic drugs with black box warnings on elderly patients with dementia; and to amend the education law, in relation to professional medical misconduct",
 "SameAsPrintNo":"A8212-2021"
}